Home / ARHGAP1 Knockout Cell Lines

ARHGAP1 Knockout Cell Lines

Gene: ARHGAP1

Official Full Name: Rho GTPase activating protein 1provided by HGNC

Gene Summary: This gene encodes a member of a large family of proteins that activate Rho-type guanosine triphosphate (GTP) metabolizing enzymes. The encoded protein contains a SRC homology 3 domain and interacts with Bcl-2-associated protein family members. [provided by RefSeq, Aug 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO38941 ARHGAP1 Knockout cell line (HeLa) Human ARHGAP1 1:3~1:6 Negative Online Inquiry
KO38942 ARHGAP1 Knockout cell line (HCT 116) Human ARHGAP1 1:2~1:4 Negative Online Inquiry
KO38943 ARHGAP1 Knockout cell line (HEK293) Human ARHGAP1 1:3~1:6 Negative Online Inquiry
KO38944 ARHGAP1 Knockout cell line (A549) Human ARHGAP1 1:3~1:4 Negative Online Inquiry

Background

ARHGAP1 Gene Knockout Cell Lines are sophisticated biological tools designed to facilitate research in cellular signaling and molecular biology. These cell lines have been engineered to specifically inhibit the activity of the ARHGAP1 gene, which encodes a Rho GTPase-activating protein involved in the regulation of the actin cytoskeleton and cell motility. By creating a knockout model for ARHGAP1, researchers can investigate its role in various physiological processes and disease states, such as cancer metastasis and neurological disorders.

The key function of these cell lines lies in their ability to mimic a loss-of-function scenario for ARHGAP1, enabling the study of downstream effects on Rho GTPase signaling pathways. Through techniques such as quantitative PCR, Western blotting, and live-cell imaging, scientists can elucidate the alterations in cellular behavior, including changes in adhesion, migration, and proliferation rates. This functional insight is invaluable for understanding the underlying mechanisms of pathologies associated with dysregulated cell signaling.

In scientific research and clinical applications, ARHGAP1 Gene Knockout Cell Lines serve as a crucial platform for discovering new therapeutic targets and testing potential interventions. Their utility extends to drug screening assays and preclinical studies aimed at improving treatment outcomes for diseases influenced by Rho GTPase signaling.

What sets these cell lines apart from alternatives is their specificity and the validated methodology used for gene knockout. Unlike traditional knockdown approaches that may leave residual gene expression, our knockout model provides a complete loss of the target gene, ensuring the reliability of experimental outcomes. Additionally, the cell lines have been rigorously characterized for consistent performance and reproducibility, qualities that are imperative for high-quality research.

For researchers and clinicians, these cell lines represent a significant advancement in molecular tools, offering the potential to uncover novel insights and develop innovative therapies. By leveraging our extensive expertise in genetic engineering and cellular biology, our company is dedicated to providing researchers with high-performance products that meet the rigorous demands of contemporary scientific inquiry.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.